Skip to main content

Table 10 Demographic and CSF findings in MOG-EM stratified according to OCB status

From: Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients

  OCB+ patients (at least once positive) OCB– patients (never positive)
Sex (m:f) Patients 1:1.5 1:1.5  
Origin (non-Caucasion:Caucasian) Patients 1:14 1:11  
Median age at first OCB+ LP Years 34 38  
Median disease duration at first OCB+ LP Months 0 (0-16) 0 (0-489)  
   OCB+ all samples OCB− all samples  
Pleocytosis Samples 13/19 (68.4%) 57/128 (44.5%) p = n.s.
WCC Samples 14 (0-151) 4 (0-463) p = n.s.
WCC > 150 Samples 1/18 (5.6%) 9/128 (7%) p = n.s.
Granulocytes Samples 3/10 (30%) 26/62 (41.9%) p = n.s.
QAlb > Qlim(Alb) Samples 11/17 (64.7%) 51/117 (43.6%) p = n.s.
CSF TP elevated Samples 8/18 (44.4%) 50/122 (41%) p = n.s.
CSF l-lactate elevated Samples 3/12 (25%) 22/91 (24.2%) p = n.s.
Treated at the time of OCB testing Samples 10/20 (50%) 48/131 (36.6%) p = n.s.
Time since attack onset Days 14 12.5  
  1. IgG-IF intrathecal IgG fraction; OCB oligoclonal bands; QAlb CSF/serum albumin quotient; TP total protein; WCC white cell count